Single-Nucleotide Polymorphisms in Thrombotic Thrombocytopenic Purpura: A Genetic Predisposition to Immune Thrombotic Thrombocytopenic Purpura. [PDF]
Konopnicki A, Rischall A, Jana B.
europepmc +1 more source
Ten tips for managing complement-mediated thrombotic microangiopathies (formerly atypical hemolytic uremic syndrome): narrative review. [PDF]
Musalem P.
europepmc +1 more source
Cost-effectiveness of caplacizumab in immune thrombotic thrombocytopenic purpura in the United States. [PDF]
Sullivan SD+3 more
europepmc +1 more source
Thrombotic thrombocytopenic purpura with juvenile systemic lupus erythematosus: successful treatment with caplacizumab and rituximab. [PDF]
Yokoyama T+7 more
europepmc +1 more source
Real-World Analysis of Clinical Characteristics, Treatment Outcomes, and the Novel Predictive Model for Patients with Thrombotic Thrombocytopenic Purpura (TTP) and TTP-Like Syndrome. [PDF]
Lv M+7 more
europepmc +1 more source
Thrombotic microangiopathic anemia in patients with sickle cell disease and its variants during a vaso-occlusive crisis. [PDF]
Bancheno W+3 more
europepmc +1 more source
Characterization of bleeding in thrombotic thrombocytopenic purpura in the precaplacizumab era: a retrospective nationwide analysis. [PDF]
Mahmoud AA+4 more
europepmc +1 more source
Congenital thrombotic thrombocytopenic purpura and human leukocyte antigen analysis-an amazing clue. [PDF]
Kıkılı Cİ+7 more
europepmc +1 more source
Taylor A, Keogh L, Dickens E, et al. Caplacizumab in pediatric immune thrombotic thrombocytopenic purpura: the UK TTP Registry experience. Blood Adv. 2024;8(17):4563-4567. [PDF]
europepmc +1 more source